Ligand validation:3WEX

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3WEX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WEX_NAG_A_201	51%	59%	0.151	0.903	0.43	1.13	-	2	1	0	100%	0.9333
3WEX_NAG_E_201	43%	60%	0.163	0.885	0.51	1.02	-	1	2	0	100%	0.9333
3WEX_NAG_G_201	37%	67%	0.181	0.88	0.56	0.71	-	-	0	0	100%	0.9333
3WEX_NAG_C_201	29%	57%	0.213	0.871	0.5	1.15	-	1	0	0	100%	0.9333
7T6I_NAG_A_201	49%	82%	0.156	0.904	0.27	0.52	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.83	0.93	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	100%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.